BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 17617156)

  • 1. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
    Gigli G; Caielli S; Cutuli D; Falcone M
    Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.
    Molling JW; Moreno M; van der Vliet HJ; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
    J Immunol Methods; 2007 Apr; 322(1-2):70-81. PubMed ID: 17343874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invariant NKT cells and tolerance.
    Nowak M; Stein-Streilein J
    Int Rev Immunol; 2007; 26(1-2):95-119. PubMed ID: 17454266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection.
    Joyee AG; Uzonna J; Yang X
    J Immunol; 2010 Feb; 184(4):2095-106. PubMed ID: 20089704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
    Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
    Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity.
    Wilson SB; Delovitch TL
    Nat Rev Immunol; 2003 Mar; 3(3):211-22. PubMed ID: 12658269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly.
    Peralbo E; DelaRosa O; Gayoso I; Pita ML; Tarazona R; Solana R
    Biogerontology; 2006; 7(5-6):483-92. PubMed ID: 16953330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
    Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
    J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
    Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
    Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis.
    Bartholomé EJ; Willems F; Crusiaux A; Thielemans K; Schandené L; Goldman M
    Acta Neurol Belg; 1999 Mar; 99(1):44-52. PubMed ID: 10218092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ex vivo expansion of Valpha24 natural killer T cells with alpha-galactosylceramide].
    Huang Y; Jiang EL; Zhou Z; He Y; Wang M; Liu QG; Zhai WJ; Han MZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):315-20. PubMed ID: 16038267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insufficient ex vivo expansion of Valpha24(+) natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14(+) cells.
    Imataki O; Heike Y; Makiyama H; Iizuka A; Ikarashi Y; Ishida T; Wakasugi H; Takaue Y
    Cytotherapy; 2008; 10(5):497-506. PubMed ID: 18608348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks.
    Mars LT; Novak J; Liblau RS; Lehuen A
    Trends Immunol; 2004 Sep; 25(9):471-6. PubMed ID: 15324739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of marginal zone B lymphocytes in invariant NKT cell activation.
    Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
    J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dangerous liaison between iNKT cells and dendritic cells: does it prevent or promote autoimmune diseases?
    Caielli S; Sorini C; Falcone M
    Autoimmunity; 2011 Feb; 44(1):11-22. PubMed ID: 20672910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.